163rd ACNFP Meeting

Last updated: 21 February 2024

The 163rd meeting of the ACNFP will be held on Wednesday the 15th of November 2023. Further details to follow.

Executive Summary

  • Dried Miracle Berry, a returning application that was assessed in April was reviewed. Members agreed that the data provided by the applicant was not sufficient to enable conclusion of the safety assessment specifically on production process and composition. The Secretariat was advised to seek this information from the applicant.
  • The Committee reviewed a draft Committee Advice Document for Magnesium-L-threonate. The document was agreed subject to amendments for clearance by Chair’s action.
  • An assessment for isomalto-oligosaccharides for use as a food supplement was considered. The response from the applicant on intended uses and anticipated intake was reviewed. The Committee considered the further information and revisions to the exposure calculation. It was advised that the Secretariat seek further advice from the Exposure Assessment Team on these estimates.  The Committee Advice Document was agreed subject to updates on the exposure for clearance by Chair’s action.
  • The Secretariat sought further advice and guidance on an application for Olive fruit dry extract standardised in hydroxytyrosol.  Clarification to inform on the drafting of the Committee Advice Document was sought on composition, specification, genotoxicity and toxicology. Further information will be sought from the applicant on these points.
  • Reserved business - The Committee was also updated on the applications received under the regulated products service as reserved business. The discussion will inform the management of applications and identification of opportunities for the assessment to be efficient and effective in achieving its goals.
  • The Committee was asked to consider the FSA’s proposal for a workshop of experts on the allergenicity of new foods to take place in February 2024. The Committee agreed with the principles outlined but suggested a Core Working Group be formed to further refine the proposal and make use of the limited time and resources available for this work. The Committee will be updated on the final agenda.
  • Reserved business - Three Committee Advice Documents for GM applications reviewed by PGT Subcommittee. ACNFP as the main committee was asked to provide governance and assurance, which was completed.
  • Reserved business -Review of the first Committee Advice Document on CBD. Refinements were made to the draft which will inform the development of future Committee Advice Documents for applications for this substance.


163rd meeting of the ACNFP 15th November 2023 Agenda


Minutes of the 163rd Meeting held on the 15th of November 2023

Meeting Papers

Dried Miracle Berry (DMB®) RP1351

Magnesium L-Threonate (Magtein®) RP956

Isomalto-Oligosaccharides RP1033

Olive Fruit Dry Extract Standardized Hydroxytyrosol RP1074

Risk Assessment of Food Allergenicity Round Table Discussion